StockData
Harrow, Inc. logo

Harrow, Inc. (HROW) stock

HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$29.52+0.43 (+1.48%)

Close on Nov 17, 2026Market cap $1.11BP/E –Yield –

Harrow pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Harrow's pe ratio was 38.8× on Oct 29, 2021, against 5.1× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2021Oct 29, 202138.8×−410.2
2020Apr 30, 2020449.0×+436.5
2019Dec 31, 201912.5×–

More Harrow figures

See a number that looks wrong?